162 related articles for article (PubMed ID: 38245723)
21. Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer.
Oshi M; Newman S; Tokumaru Y; Yan L; Matsuyama R; Endo I; Nagahashi M; Takabe K
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933189
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
23. Epirubicin suppresses proliferative and metastatic potential by downregulating transforming growth factor-β-induced expression in urothelial carcinoma.
Shang D; Song B; Liu Y
Cancer Sci; 2018 Apr; 109(4):980-987. PubMed ID: 28940965
[TBL] [Abstract][Full Text] [Related]
24. Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer.
Chen WY; Tsai YC; Yeh HL; Suau F; Jiang KC; Shao AN; Huang J; Liu YN
Sci Signal; 2017 Aug; 10(492):. PubMed ID: 28811384
[TBL] [Abstract][Full Text] [Related]
25. TGFβ isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implications.
Chen C; Zhao KN; Masci PP; Lakhani SR; Antonsson A; Simpson PT; Vitetta L
BMC Cancer; 2015 Dec; 15():1010. PubMed ID: 26703884
[TBL] [Abstract][Full Text] [Related]
26. Bcl-3 regulates TGFβ signaling by stabilizing Smad3 during breast cancer pulmonary metastasis.
Chen X; Cao X; Sun X; Lei R; Chen P; Zhao Y; Jiang Y; Yin J; Chen R; Ye D; Wang Q; Liu Z; Liu S; Cheng C; Mao J; Hou Y; Wang M; Siebenlist U; Eugene Chin Y; Wang Y; Cao L; Hu G; Zhang X
Cell Death Dis; 2016 Dec; 7(12):e2508. PubMed ID: 27906182
[TBL] [Abstract][Full Text] [Related]
27. TGF-β-induced (TGFBI) protein in melanoma: a signature of high metastatic potential.
Lauden L; Siewiera J; Boukouaci W; Ramgolam K; Mourah S; Lebbe C; Charron D; Aoudjit F; Jabrane-Ferrat N; Al-Daccak R
J Invest Dermatol; 2014 Jun; 134(6):1675-1685. PubMed ID: 24499734
[TBL] [Abstract][Full Text] [Related]
28. HER2 mediated de novo production of TGFβ leads to SNAIL driven epithelial-to-mesenchymal transition and metastasis of breast cancer.
Gupta P; Srivastava SK
Mol Oncol; 2014 Dec; 8(8):1532-47. PubMed ID: 24994678
[TBL] [Abstract][Full Text] [Related]
29. Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
Novitskiy SV; Forrester E; Pickup MW; Gorska AE; Chytil A; Aakre M; Polosukhina D; Owens P; Yusupova DR; Zhao Z; Ye F; Shyr Y; Moses HL
Breast Cancer Res; 2014 Oct; 16(5):425. PubMed ID: 25280532
[TBL] [Abstract][Full Text] [Related]
30. TGFBI expression is associated with a better response to chemotherapy in NSCLC.
Irigoyen M; Pajares MJ; Agorreta J; Ponz-Sarvisé M; Salvo E; Lozano MD; Pío R; Gil-Bazo I; Rouzaut A
Mol Cancer; 2010 May; 9():130. PubMed ID: 20509890
[TBL] [Abstract][Full Text] [Related]
31. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
[TBL] [Abstract][Full Text] [Related]
32. TGFβ regulates NK1R-Tr to affect the proliferation and apoptosis of breast cancer cells.
Wang L; Wang N; Zhang R; Dong D; Liu R; Zhang L; Ji W; Yu M; Zhang F; Niu R; Zhou Y
Life Sci; 2020 Sep; 256():117674. PubMed ID: 32380077
[TBL] [Abstract][Full Text] [Related]
33. TGFBI protein high expression predicts poor prognosis in colorectal cancer patients.
Zhu J; Chen X; Liao Z; He C; Hu X
Int J Clin Exp Pathol; 2015; 8(1):702-10. PubMed ID: 25755764
[TBL] [Abstract][Full Text] [Related]
34. Comprehensively investigating the expression levels and the prognostic role of transforming growth factor beta-induced (TGFBI) in glioblastoma multiforme.
Yin J; Liu JS; Feng M; Li JM; Lu S; Yang M; Cao BR; Lang JY; Zhu XD
Transl Cancer Res; 2020 Oct; 9(10):6487-6504. PubMed ID: 35117257
[TBL] [Abstract][Full Text] [Related]
35. Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR.
Shah JN; Shao G; Hei TK; Zhao Y
BMC Cancer; 2008 Oct; 8():284. PubMed ID: 18834524
[TBL] [Abstract][Full Text] [Related]
36. HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGFβ-signaling in hypoxic microenvironment.
Nagpal N; Ahmad HM; Chameettachal S; Sundar D; Ghosh S; Kulshreshtha R
Sci Rep; 2015 Apr; 5():9650. PubMed ID: 25867965
[TBL] [Abstract][Full Text] [Related]
37. The Outcome of TGFβ Antagonism in Metastatic Breast Cancer Models
Yang Y; Yang HH; Tang B; Wu AML; Flanders KC; Moshkovich N; Weinberg DS; Welsh MA; Weng J; Ochoa HJ; Hu TY; Herrmann MA; Chen J; Edmondson EF; Simpson RM; Liu F; Liu H; Lee MP; Wakefield LM
Clin Cancer Res; 2020 Feb; 26(3):643-656. PubMed ID: 31582516
[TBL] [Abstract][Full Text] [Related]
38. Metastatic heterogeneity of breast cancer cells is associated with expression of a heterogeneous TGFβ-activating miR424-503 gene cluster.
Li Y; Li W; Ying Z; Tian H; Zhu X; Li J; Li M
Cancer Res; 2014 Nov; 74(21):6107-18. PubMed ID: 25164015
[TBL] [Abstract][Full Text] [Related]
39. Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231.
Morini M; Astigiano S; Gitton Y; Emionite L; Mirisola V; Levi G; Barbieri O
BMC Cancer; 2010 Nov; 10():649. PubMed ID: 21108812
[TBL] [Abstract][Full Text] [Related]
40. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]